Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory

Trends in Neurosciences

Volumn 29, Issue 12, 2006, Pages 679-686

  Mansuy, Isabelle M ^a   Shenolikar, Shirish ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMYLOID; CALCINEURIN; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN SERINE THREONINE KINASE;

CELL COMPARTMENTALIZATION; DEMENTIA; LEARNING DISORDER; MAMMAL; MEMORY DISORDER; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SYNAPSE;

ANIMALS; BRAIN; HUMANS; LEARNING DISORDERS; MEMORY DISORDERS; NEURONAL PLASTICITY; PHOSPHOPROTEIN PHOSPHATASE; SERINE; THREONINE;

EID: 33751268368     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2006.10.004     Document Type: Review

References (119)

1. Artola A., and Singer W. Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation. Trends Neurosci. 16 (1993) 480-487
2. Bear M.F., et al. A physiological basis for a theory of synapse modification. Science 237 (1987) 42-48
3. Sheppeck II J.E., et al. Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins. Bioorg. Med. Chem. 5 (1997) 1739-1750
4. Martinez-Martinez S., and Redondo J.M. Inhibitors of the calcineurin/NFAT pathway. Curr. Med. Chem. 11 (2004) 997-1007
5. Favre B., et al. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J. Biol. Chem. 272 (1997) 13856-13863
6. Rogers J.P., et al. Discovery of protein phosphatase 2C inhibitors by virtual screening. J. Med. Chem. 49 (2006) 1658-1667
7. Shields S.M., et al. Identification of protein phosphatase 1 in synaptic junctions: dephosphorylation of endogenous calmodulin-dependent kinase II and synapse-enriched phosphoproteins. J. Neurosci. 5 (1985) 3414-3422
8. Strack S., et al. Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase II to the postsynaptic density. J. Biol. Chem. 272 (1997) 13467-13470
9. Bauman A.L., and Scott J.D. Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo. Nat. Cell Biol. 4 (2002) E203-E206
10. Cohen P.T. Protein phosphatase 1-targeted in many directions. J. Cell Sci. 115 (2002) 241-256
11. Vietri M., et al. Direct interaction between the catalytic subunit of protein phosphatase 1 and pRb. Cancer Cell Int. 6 (2006) 3
12. Li H., et al. Structural delineation of the calcineurin-NFAT interaction and its parallels to PP1 targeting interactions. J. Mol. Biol. 342 (2004) 1659-1674
13. Zhang J., et al. Protein phosphatase 5 is required for ATR-mediated checkpoint activation. Mol. Cell. Biol. 25 (2005) 9910-9919
14. Zhang X., et al. Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 19 (2005) 827-839
15. Zhu T., et al. Association of cystic fibrosis transmembrane conductance regulator and protein phosphatase 2C. J. Biol. Chem. 274 (1999) 29102-29107
16. Oliver C.J., et al. Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology. Mol. Cell. Biol. 22 (2002) 4690-4701
17. Connor J.H., et al. Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol. Cell. Biol. 21 (2001) 6841-6850
18. Eto M., et al. Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8888-8893
19. Terry-Lorenzo R.T., et al. Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton. J. Biol. Chem. 277 (2002) 46535-46543
20. Janssens V., et al. PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev. 15 (2005) 34-41
21. Kloeker S., et al. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with α4 protein. Protein Expr. Purif. 31 (2003) 19-33
22. Dodge K.L., and Scott J.D. Calcineurin anchoring and cell signaling. Biochem. Biophys. Res. Commun. 311 (2003) 1111-1115
23. Kloeker S., and Wadzinski B.E. Purification and identification of a novel subunit of protein serine/threonine phosphatase 4. J. Biol. Chem. 274 (1999) 5339-5347
24. Dagda R.K., et al. A developmentally regulated, neuron-specific splice variant of the variable subunit Bβ targets protein phosphatase 2A to mitochondria and modulates apoptosis. J. Biol. Chem. 278 (2003) 24976-24985
25. Ehlers M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 6 (2003) 231-242
26. Strack S., et al. Protein phosphatase 2A holoenzyme assembly: identification of contacts between B-family regulatory and scaffolding A subunits. J. Biol. Chem. 277 (2002) 20750-20755
27. Trockenbacher A., et al. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat. Genet. 29 (2001) 287-294
28. Swope S.L., et al. Regulation of ligand-gated ion channels by protein phosphorylation. Adv. Second Messenger Phosphoprotein Res. 33 (1999) 49-78
29. 2+-dependent phosphatase. Nature 369 (1994) 235-239
30. Krupp J.J., et al. Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors. Neuropharmacology 42 (2002) 593-602
31. Tong G., and Jahr C.E. Regulation of glycine-insensitive desensitization of the NMDA receptor in outside-out patches. J. Neurophysiol. 72 (1994) 754-761
32. Tong G., et al. Synaptic desensitization of NMDA receptors by calcineurin. Science 267 (1995) 1510-1512
33. 2-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr. Biol. 10 (2000) 409-412
34. Alagarsamy S., et al. NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin. Neuropharmacology 49 Suppl. 1 (2005) 135-145
35. Suzuki K., et al. Neuronal depolarization controls brain-derived neurotrophic factor-induced upregulation of NR2C NMDA receptor via calcineurin signaling. J. Neurosci. 25 (2005) 9535-9543
36. Townsend M., et al. Retina-driven dephosphorylation of the NR2A subunit correlates with faster NMDA receptor kinetics at developing retinocollicular synapses. J. Neurosci. 24 (2004) 11098-11107
37. Wang L.Y., et al. Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. Nature 369 (1994) 230-232
38. Westphal R.S., et al. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science 285 (1999) 93-96
39. Chergui K., et al. Physiological role for casein kinase 1 in glutamatergic synaptic transmission. J. Neurosci. 25 (2005) 6601-6609
40. Boehm J., et al. Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1. Neuron 51 (2006) 213-225
41. Wang J.Q., et al. Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity. Mol. Neurobiol. 32 (2005) 237-249
42. Ehlers M.D. Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28 (2000) 511-525
43. Oh M.C., et al. Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation. J. Biol. Chem. 281 (2006) 752-758
44. Carnegie G.K., and Scott J.D. A-kinase anchoring proteins and neuronal signaling mechanisms. Genes Dev. 17 (2003) 1557-1568
45. Slepnev V.I., et al. Role of phosphorylation in regulation of the assembly of endocytic coat complexes. Science 281 (1998) 821-824
46. Beattie E.C., et al. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci. 3 (2000) 1291-1300
47. McAvoy T., et al. Regulation of neurabin I interaction with protein phosphatase 1 by phosphorylation. Biochemistry 38 (1999) 12943-12949
48. Terry-Lorenzo R.T., et al. Neurabin/protein phosphatase-1 complex regulates dendritic spine morphogenesis and maturation. Mol. Biol. Cell 16 (2005) 2349-2362
49. Tomita S., et al. Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs. Neuron 45 (2005) 269-277
50. Allen P.B., et al. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience 140 (2006) 897-911
51. Feng J., et al. Spinophilin regulates the formation and function of dendritic spines. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9287-9292
52. Hsieh-Wilson L.C., et al. Characterization of the neuronal targeting protein spinophilin and its interactions with protein phosphatase-1. Biochemistry 38 (1999) 4365-4373
53. Yan Z., et al. Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin. Nat. Neurosci. 2 (1999) 13-17
54. Ingebritsen T.S., and Cohen P. Protein phosphatases: properties and role in cellular regulation. Science 221 (1983) 331-338
55. Nishi A., et al. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. J. Neurochem. 81 (2002) 832-841
56. Valjent E., et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 491-496
57. 2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. J. Biol. Chem. 277 (2002) 36553-36562
58. Snyder G.L., et al. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci. 20 (2000) 4480-4488
59. Michel J.J., and Scott J.D. AKAP mediated signal transduction. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 235-257
60. Lin J.W., et al. Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1. J. Neurosci. 18 (1998) 2017-2027
61. Wang J., et al. Interaction of calcineurin and type-A GABA receptor γ2 subunits produces long-term depression at CA1 inhibitory synapses. J. Neurosci. 23 (2003) 826-836
62. Wang X., et al. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J. Neurosci. 22 (2002) 9185-9193
63. A receptor phospho-dependent modulation is regulated by phospholipase C-related inactive protein type 1, a novel protein phosphatase 1 anchoring protein. J. Neurosci. 24 (2004) 7074-7084
64. A receptor phosphorylation, activity, and cell-surface stability. J. Neurosci. 24 (2004) 522-530
65. Yoshimura K., et al. Interaction of p130 with, and consequent inhibition of, the catalytic subunit of protein phosphatase 1α. J. Biol. Chem. 276 (2001) 17908-17913
66. Blitzer R.D., et al. Postsynaptic signaling networks: cellular cogwheels underlying long-term plasticity. Biol. Psychiatry 57 (2005) 113-119
67. Montgomery J.M., and Madison D.V. Discrete synaptic states define a major mechanism of synapse plasticity. Trends Neurosci. 27 (2004) 744-750
68. Flajolet M., et al. Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 16006-16011
69. 2+ channels phosphorylated by protein kinase C. J. Neurosci. 25 (2005) 1914-1923
70. Colbran R.J. Targeting of calcium/calmodulin-dependent protein kinase II. Biochem. J. 378 (2004) 1-16
71. Otmakhov N., et al. Persistent accumulation of calcium/calmodulin-dependent protein kinase II in dendritic spines after induction of NMDA receptor-dependent chemical long-term potentiation. J. Neurosci. 24 (2004) 9324-9331
72. 2+/calmodulin-dependent protein kinase II and protein phosphatase 1 during hippocampal long-term potentiation. J. Neurosci. 25 (2005) 5604-5610
73. Morishita W., et al. Regulation of synaptic strength by protein phosphatase 1. Neuron 32 (2001) 1133-1148
74. Bordelon J.R., et al. Differential localization of protein phosphatase-1α, β and γ1 isoforms in primate prefrontal cortex. Cereb. Cortex 15 (2005) 1928-1937
75. 1 dopamine receptor in primate prefrontal cortex: evidence for discrete populations of spines. J. Comp. Neurol. 440 (2001) 261-270
76. Kennedy M.J., and Ehlers M.D. Organelles and trafficking machinery for postsynaptic plasticity. Annu. Rev. Neurosci. 29 (2006) 325-362
77. Runyan J.D., et al. A role for prefrontal calcium-sensitive protein phosphatase and kinase activities in working memory. Learn. Mem. 12 (2005) 103-110
78. Monti B., et al. Dysregulation of memory-related proteins in the hippocampus of aged rats and their relation with cognitive impairment. Hippocampus 15 (2005) 1041-1049
79. Cannich A., et al. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learn. Mem. 11 (2004) 625-632
80. Lin C.H., et al. Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Mol. Pharmacol. 63 (2003) 44-52
81. Lin C.H., et al. Identification of calcineurin as a key signal in the extinction of fear memory. J. Neurosci. 23 (2003) 1574-1579
82. Lin C.H., et al. The similarities and diversities of signal pathways leading to consolidation of conditioning and consolidation of extinction of fear memory. J. Neurosci. 23 (2003) 8310-8317
83. Mansuy I.M., et al. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 92 (1998) 39-49
84. Mansuy I.M., et al. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 21 (1998) 257-265
85. Heyser C.J., et al. DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Res. 867 (2000) 122-130
86. Allen P.B., et al. Protein phosphatase-1 regulation in the induction of long-term potentiation: heterogeneous molecular mechanisms. J. Neurosci. 20 (2000) 3537-3543
87. Ikegami S., and Inokuchi K. Antisense DNA against calcineurin facilitates memory in contextual fear conditioning by lowering the threshold for hippocampal long-term potentiation induction. Neuroscience 98 (2000) 637-646
88. Malleret G., et al. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 104 (2001) 675-686
89. Sharma S.K., et al. Inhibition of calcineurin facilitates the induction of memory for sensitization in Aplysia: requirement of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4861-4866
90. Genoux D., et al. Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418 (2002) 970-975
91. Bennett P.C., et al. Concentration-dependent effects of protein phosphatase (PP) inhibitors implicate PP1 and PP2A in different stages of memory formation. Neurobiol. Learn. Mem. 75 (2001) 91-110
92. Zeng H., et al. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107 (2001) 617-629
93. Stafstrom-Davis C.A., et al. Impaired conditioned taste aversion learning in spinophilin knockout mice. Learn. Mem. 8 (2001) 272-278
94. a2+ dysregulation with brain aging. J. Neurosci. 21 (2001) 4066-4073
95. Jouvenceau A., and Dutar P. A role for the protein phosphatase 2B in altered hippocampal synaptic plasticity in the aged rat. J. Physiol. (Paris) 99 (2006) 154-161
96. Agbas A., et al. Decreased activity and increased aggregation of brain calcineurin during aging. Brain Res. 1059 (2005) 59-71
97. Cook C.N., et al. Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease. J. Alzheimers Dis. 8 (2005) 63-73
98. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3 (2002) 862-872
99. Mattson M.P., and Chan S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34 (2003) 385-397
100. Buerger K., et al. CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology 59 (2002) 627-629
101. Liu F., et al. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22 (2005) 1942-1950
102. Tian Q., and Wang J. Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals 11 (2002) 262-269
103. Hata R., et al. Up-regulation of calcineurin Aβ mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem. Biophys. Res. Commun. 284 (2001) 310-316
104. Liu F., et al. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J. Biol. Chem. 280 (2005) 37755-37762
105. Raha-Chowdhury R., et al. CAT 53: a protein phosphatase 1 nuclear targeting subunit encoded in the MHC Class I region strongly expressed in regions of the brain involved in memory, learning, and Alzheimer's disease. Mol. Brain Res. 138 (2005) 70-83
106. Tanimukai H., et al. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am. J. Pathol. 166 (2005) 1761-1771
107. Keating D.J., et al. Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins. DSCR1 and ITSN1. Ageing Res. Rev. 5 (2006) 388-401
108. Lim J., and Lu K.P. Pinning down phosphorylated tau and tauopathies. Biochim. Biophys. Acta 1739 (2005) 311-322
109. Sun L., et al. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118 (2003) 1175-1182
110. da Cruz e Silva E.F., et al. Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein. Mol. Med. 1 (1995) 535-541
111. Cardoso S.M., and Oliveira C.R. The role of calcineurin in amyloid-β-peptides-mediated cell death. Brain Res. 1050 (2005) 1-7
112. Chen Q.S., et al. Alzheimer amyloid β-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 77 (2002) 354-371
113. Kamenetz F., et al. APP processing and synaptic function. Neuron 37 (2003) 925-937
114. Snyder E.M., et al. Regulation of NMDA receptor trafficking by amyloid-β. Nat. Neurosci. 8 (2005) 1051-1058
115. Zhao D., et al. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. J. Neurophysiol. 92 (2004) 2853-2858
116. Gerdjikov T.V., and Beninger R.J. Differential effects of calcineurin inhibition and protein kinase A activation on nucleus accumbens amphetamine-produced conditioned place preference in rats. Eur. J. Neurosci. 22 (2005) 697-705
117. Biala G., et al. The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. Eur. J. Neurosci. 21 (2005) 3089-3096
118. Zachariou V., et al. Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1. Biol. Psychiatry 51 (2002) 612-620
119. Gerdjikov T.V., et al. Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats. Behav. Neurosci. 118 (2004) 740-750